Related Experiment Video
Updated: May 2, 2026
06:55
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.3K
Performing meta-analysis with incomplete statistical information in clinical trials.
Jianbing Ma1, Weiru Liu, Anthony Hunter
1School of Electronics, Electrical Engineering and Computer Science, Queen's University Belfast, Belfast, BT7 1NN, UK. jma03@qub.ac.uk
BMC Medical Research Methodology
|August 19, 2008
Summary
New prognostic and interval methods estimate missing standard error of the mean (SEM) in meta-analysis. These methods improve upon traditional approaches that ignore incomplete data, offering more accurate and cautious results for clinical trial analysis.
Area of Science:
- Biostatistics
- Clinical Trials
- Medical Research
Background:
- Meta-analysis combines results from multiple clinical trials.
- Incomplete data (missing standard error of the mean) poses challenges for meta-analysis.
- Current methods for handling missing SEMs have significant drawbacks.
Purpose of the Study:
- To develop and test novel methods for estimating missing SEMs in meta-analysis.
- To provide alternatives to ignoring trials or imputing SEMs from similar trials.
- To enable more comprehensive meta-analyses with incomplete data.
Main Methods:
- Prognostic Method: Predicts missing SEMs based on existing SEMs from similar trials.
- Interval Method: Defines plausible intervals for missing SEMs and incorporates them into the analysis.
- Both methods assume random sampling from the same population.
Main Results:
- Both methods accurately approximate conventional meta-analysis results when applied to incomplete datasets.
- Demonstrated utility in trials comparing drugs for low-density lipoprotein cholesterol reduction and intraocular pressure lowering.
- Prognostic method yielded results close to full information analysis; interval method provided a range of plausible outcomes.
Conclusions:
- The prognostic and interval methods are effective alternatives for handling missing SEM data in meta-analysis.
- The prognostic method is recommended for predicting SEMs to perform meta-analysis.
- The interval method is suggested for obtaining more conservative and cautious results.
Related Concept Videos
01:16Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
01:11Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
363
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
363
01:24Kaplan-Meier Approach
792
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
792
01:20Comparing the Survival Analysis of Two or More Groups
712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712